Related Experiment Video
Updated: May 18, 2026
08:49
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Serotonin receptors involved in antidepressant effects
1Department of Neurochemistry and Neuropharmacology, IIBB-CSIC, IDIBAPS, Rosselló 161, 6th floor, 08036 Barcelona, Spain. fapnqi@iibb.csic.es
Pharmacology & Therapeutics
|October 2, 2012
Summary
Serotonin (5-HT) receptor roles in depression treatment are complex. Targeting specific 5-HT receptors, like blocking presynaptic autoreceptors and stimulating postsynaptic ones, may improve antidepressant efficacy and speed.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Serotonin (5-HT) is crucial in major depression pathophysiology and treatment.
- Current antidepressants like SSRIs and SNRIs have limitations in efficacy and speed.
- The precise neurobiological mechanisms of antidepressant action remain poorly understood.
Purpose of the Study:
- To review preclinical and clinical evidence on 5-HT receptor involvement in antidepressant drug action.
- To elucidate the roles of various 5-HT receptors in therapeutic outcomes.
- To identify potential new therapeutic targets for depression.
Main Methods:
- Review of existing preclinical research.
- Analysis of clinical trial data.
- Examination of evidence for specific 5-HT receptor subtypes (e.g., 5-HT1A, 5-HT2, 5-HT3, 5-HT4, 5-HT6, 5-HT7).
Main Results:
- Presynaptic 5-HT1A and 5-HT1B autoreceptors negatively impact treatment by reducing serotonergic function.
- Postsynaptic 5-HT1A receptor stimulation in corticolimbic networks is beneficial.
- Blocking 5-HT2A/2C receptors enhances SSRI efficacy; 5-HT2B activation may boost serotonin.
- Blocking 5-HT3, 5-HT6, and 5-HT7 receptors can augment antidepressant effects.
Conclusions:
- Different 5-HT receptor subtypes play distinct, often opposing, roles in antidepressant therapy.
- Targeting specific 5-HT receptors offers potential for improved depression treatments.
- Understanding these receptor interactions is key to overcoming current treatment limitations.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...